References
- Van der ValkRWebersCAJanSAIntraocular pressure-lowering effects of all commonly used glaucoma drugsOphthalmology20051121177118515921747
- AraieMAbeHThe Japan Glaucoma Society Guidelines for Glaucoma, 2nd edJpn J Ophthalmol Soc2006110777814
- AraieMKitazawaYAzumaIThe efficacy and safety of dose escalation of dorzolamide used in combination with other topical anti-glaucoma agentsJ Ocul Pharmacol Ther20031951752514733709
- NakamuraYIshikawaSNakamuraY24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprostClin Ophthalmol2009339540019688026
- MaruyamaKShiratoSAdditive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma. A prospective randomized crossover trialJ Glaucoma20061534134516865013
- O’ConnorDJMartoneJFMeadAAdditive intraocular pressure lowering effect of various medications with latanoprostAm J Ophthalmol200213383683712036683
- TamerCÖksüzHCircadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprostOphthalmic Res200739243117164574
- BourniasTELaiJBrimonidinetartate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogsOphthalmology20091161719172419592108
- BoyerSGayDAdditive effect of dorzolamide hydrochloride to patients taking travoprost: A retrospective studyOptometry20087950150418722961
- AriciMKTopalkaraAGulerCAdditive effect of latanoprost and dorzolamide in patients with elevated intraocular pressureInter Ophthalmol1998223742
- InoueKWakakuraMKinugawaYShort-term hypotensive effect of dorzolamide added to prostaglandin-related topical medicationJpn J Clin Ophthalmol201064725728